Brightleaf Square secures first life science tenant
Oerth Bio has signed a lease for approximately 15,000 square feet of office and lab space
October 22 2020, Durham, NC – Brightleaf Square is excited to welcome its first life science tenant, Oerth Bio, who will occupy approximately 15,000 square feet of office and lab space. Oerth Bio, a joint venture between Arvinas and Bayer, is leading a new and transformative approach to crop protection, crop health, and healthy food by leveraging its proprietary targeted protein degradation technology.
“We are really looking forward to calling Brightleaf Square home. This historic property provides exactly the vibe we are looking for and will enable us to recruit and retain top talent in the life science industry.” Paul Boyer, Chief Financial Officer at Oerth Bio said.
Brightleaf Square features a unique mix of locally owned restaurants, shops, and workspaces in downtown Durham. The property occupies the former Watts and Yuille tobacco warehouses, originally built in 1900 and 1904, bringing a historic, industrial ambiance to its tenants and guests.
JLL’s John MacDonell and Taylor McCuiston represented the landlord in the transaction.
About JLL
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $18.0 billion in 2019, operations in over 80 countries and a global workforce of nearly 93,000 as of June 30, 2020. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.
About Oerth Bio
Oerth Bio is rewriting the next 100 years of farming by leading a new and transformative approach to crop protection, crop health resilience, and healthy nutritional food by leveraging our proprietary PROTAC® protein degraders, or proteolysis-targeting chimeras. PROTAC protein degraders work by harnessing the plant's own natural protein disposal system to degrade and remove unwanted proteins. Oerth Bio is a joint venture between Arvinas and Bayer, supported by $56 million in committed funding. Oerth is located in Durham, North Carolina. Please visit www.oerthbio.com for more information.